478 related articles for article (PubMed ID: 33912131)
21. Maternal occupational exposure to endocrine-disrupting chemicals during pregnancy and semen parameters in adulthood: results of a nationwide cross-sectional study among Swiss conscripts.
Istvan M; Rahban R; Dananche B; Senn A; Stettler E; Multigner L; Nef S; Garlantézec R
Hum Reprod; 2021 Jun; 36(7):1948-1958. PubMed ID: 33729457
[TBL] [Abstract][Full Text] [Related]
22. The effects of endocrine-disrupting chemicals on ovarian- and ovulation-related fertility outcomes.
Land KL; Miller FG; Fugate AC; Hannon PR
Mol Reprod Dev; 2022 Dec; 89(12):608-631. PubMed ID: 36580349
[TBL] [Abstract][Full Text] [Related]
23. Endocrine disrupting chemicals (EDCs) and sex steroid receptors.
Hall JM; Korach KS
Adv Pharmacol; 2021; 92():191-235. PubMed ID: 34452687
[TBL] [Abstract][Full Text] [Related]
24. Perinatal exposure to endocrine disrupting chemicals and neurodevelopment: How articles of daily use influence the development of our children.
O'Shaughnessy KL; Fischer F; Zenclussen AC
Best Pract Res Clin Endocrinol Metab; 2021 Sep; 35(5):101568. PubMed ID: 34565681
[TBL] [Abstract][Full Text] [Related]
25. Neuroendocrine and behavioral implications of endocrine disrupting chemicals in quail.
Ottinger MA; Abdelnabi MA; Henry P; McGary S; Thompson N; Wu JM
Horm Behav; 2001 Sep; 40(2):234-47. PubMed ID: 11534988
[TBL] [Abstract][Full Text] [Related]
26. Prednisolone in early pregnancy inhibits regulatory T cell generation and alters fetal and placental development in mice.
Kieffer TE; Chin PY; Green ES; Moldenhauer LM; Prins JR; Robertson SA
Mol Hum Reprod; 2020 May; 26(5):340-352. PubMed ID: 32159777
[TBL] [Abstract][Full Text] [Related]
27. Impact of endocrine-disrupting compounds (EDCs) on female reproductive health.
Fowler PA; Bellingham M; Sinclair KD; Evans NP; Pocar P; Fischer B; Schaedlich K; Schmidt JS; Amezaga MR; Bhattacharya S; Rhind SM; O'Shaughnessy PJ
Mol Cell Endocrinol; 2012 May; 355(2):231-9. PubMed ID: 22061620
[TBL] [Abstract][Full Text] [Related]
28. Male pubertal development: are endocrine-disrupting compounds shifting the norms?
Zawatski W; Lee MM
J Endocrinol; 2013; 218(2):R1-12. PubMed ID: 23709001
[TBL] [Abstract][Full Text] [Related]
29. Molecular mechanism(s) of endocrine-disrupting chemicals and their potent oestrogenicity in diverse cells and tissues that express oestrogen receptors.
Lee HR; Jeung EB; Cho MH; Kim TH; Leung PC; Choi KC
J Cell Mol Med; 2013 Jan; 17(1):1-11. PubMed ID: 23279634
[TBL] [Abstract][Full Text] [Related]
30. Clinical epidemiology studies on potential effects of endocrine disrupting chemicals (EDCs) should exclude subjects with obesity as determined by BMI.
Smith CJ; Perfetti TA; Hayes AW; Berry SC
Regul Toxicol Pharmacol; 2020 Aug; 115():104711. PubMed ID: 32598900
[TBL] [Abstract][Full Text] [Related]
31. Obesogens: an emerging threat to public health.
Janesick AS; Blumberg B
Am J Obstet Gynecol; 2016 May; 214(5):559-65. PubMed ID: 26829510
[TBL] [Abstract][Full Text] [Related]
32. Impact of gestational exposure to endocrine disrupting chemicals on pregnancy and birth outcomes.
Padmanabhan V; Moeller J; Puttabyatappa M
Adv Pharmacol; 2021; 92():279-346. PubMed ID: 34452689
[TBL] [Abstract][Full Text] [Related]
33. Prenatal Exposure to Endocrine-Disrupting Chemicals and Asthma and Allergic Diseases.
Casas M; Gascon M
J Investig Allergol Clin Immunol; 2020; 30(4):215-228. PubMed ID: 32490822
[TBL] [Abstract][Full Text] [Related]
34. Sex-specific enhanced behavioral toxicity induced by maternal exposure to a mixture of low dose endocrine-disrupting chemicals.
Sobolewski M; Conrad K; Allen JL; Weston H; Martin K; Lawrence BP; Cory-Slechta DA
Neurotoxicology; 2014 Dec; 45():121-30. PubMed ID: 25454719
[TBL] [Abstract][Full Text] [Related]
35. Effects of endocrine disrupting chemicals in pigs.
Yang C; Song G; Lim W
Environ Pollut; 2020 Aug; 263(Pt B):114505. PubMed ID: 32268228
[TBL] [Abstract][Full Text] [Related]
36. An inadvertent issue of human retina exposure to endocrine disrupting chemicals: A safety assessment.
Li M; Yang T; Gao L; Xu H
Chemosphere; 2021 Feb; 264(Pt 1):128484. PubMed ID: 33022499
[TBL] [Abstract][Full Text] [Related]
37. Toxicant exposure during pregnancy increases protective proteins in the dam and a sexually dimorphic response in the fetus.
Rister AL; Amato CM; Nash T; McCoy MW; Bereman M; McCoy KA
Toxicol Appl Pharmacol; 2021 Feb; 413():115407. PubMed ID: 33434571
[TBL] [Abstract][Full Text] [Related]
38. Implications of Prenatal Exposure to Endocrine-Disrupting Chemicals in Offspring Development: A Narrative Review.
Toledano JM; Puche-Juarez M; Moreno-Fernandez J; Gonzalez-Palacios P; Rivas A; Ochoa JJ; Diaz-Castro J
Nutrients; 2024 May; 16(11):. PubMed ID: 38892490
[TBL] [Abstract][Full Text] [Related]
39. Immune-Metabolic Interactions and T Cell Tolerance in Pregnancy.
Moldenhauer LM; Hull ML; Foyle KL; McCormack CD; Robertson SA
J Immunol; 2022 Oct; 209(8):1426-1436. PubMed ID: 36192117
[TBL] [Abstract][Full Text] [Related]
40. Endocrine-disrupting chemicals and human growth and maturation: a focus on early critical windows of exposure.
Fudvoye J; Bourguignon JP; Parent AS
Vitam Horm; 2014; 94():1-25. PubMed ID: 24388185
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
